A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.

Georgescu, Constantin; Corbin, Joshua M; Thibivilliers, Sandra; Webb, Zachary D; Zhao, Yan D; Koster, Jan; Fung, Kar-Ming; Asch, Adam S; Wren, Jonathan D; Ruiz-Echevarría, Maria J.
BMC Cancer; 19(1): 423, 2019 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-31060542